413 GEN-009, a personalized neoantigen vaccine, elicits robust immune responses in individuals with advanced or metastatic solid tumors

• Thomas Davis,
• Jessica Flechtner,
• Mara Shainheit,
• Devin Champagne,
• Gabriella Santone,
• Syukri Shukor,
• Ece Bicak,
• Samuel Tipps,
• Li Xue

Affiliations

Thomas Davis

7Genocea Biosciences, Centreville, MD, USA

Jessica Flechtner

Aff1 grid.475330.60000000405579162Genocea Biosciences, Inc Cambridge MA USA

Mara Shainheit

7Genocea Biosciences, Centreville, MD, USA

Devin Champagne

Genocea Biosciences, Cambridge, MA, USA

Gabriella Santone

Genocea Biosciences, Cambridge, MA, USA

Syukri Shukor

Genocea Biosciences, Cambridge, MA, USA

Ece Bicak

Genocea Biosciences, Cambridge, MA, USA

Samuel Tipps

Genocea Biosciences, Cambridge, MA, USA

Li Xue

Genocea Biosciences, Cambridge, MA, USA